IMMUNE-MEDIATED NECROTISING MYOPATHY

This adverse event was reported 567 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED NECROTISING MYOPATHY:

# Drug Count
0 ATORVASTATIN CALCIUM 151
1 ATORVASTATIN CALCIUM, FILM COATED 137
2 SIMVASTATIN 99
3 METFORMIN 52
4 METFORMIN ER 500 MG 47
5 METFORMIN ER 750 MG 47
6 ROSUVASTATIN CALCIUM 40
7 EZETIMIBE 34
8 ROSUVASTATIN 32
9 PREDNISOLONE 29
See all common drugs associated with IMMUNE-MEDIATED NECROTISING MYOPATHY

IMMUNE-MEDIATED NECROTISING MYOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EZETIMIBE 34 0.0010
1 ATORVASTATIN CALCIUM 151 0.0008
2 SOTALOL HYDROCHLORIDE TABLES AF 1 0.0007
3 SOTALOL HYDROCHLORIDE TABLETS AF 1 0.0007
4 SCOPOLAMINE 1 0.0005
5 SIMVASTATIN 99 0.0005
6 ACETYLSALICYLIC ACID 17 0.0004
7 PEMBROLIZUMAB 9 0.0004
8 PITAVASTATIN CALCIUM 2 0.0004
9 REPAGLINIDE 2 0.0003
See all drugs enriched for association with IMMUNE-MEDIATED NECROTISING MYOPATHY

These drug classes are most commonly taken by patients reporting IMMUNE-MEDIATED NECROTISING MYOPATHY:

# Drug class Count
0 Purine Antimetabolite [EPC] 13
1 Angiotensin Converting Enzyme Inhibitor [EPC] 12
2 Insulin Analog [EPC] 9
See all common drug classes associated with IMMUNE-MEDIATED NECROTISING MYOPATHY

IMMUNE-MEDIATED NECROTISING MYOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Purine Antimetabolite [EPC] 13 0.0003
1 Angiotensin Converting Enzyme Inhibitor [EPC] 12 0.0001
2 Insulin Analog [EPC] 9 0.0000
See all drug classes enriched for association with IMMUNE-MEDIATED NECROTISING MYOPATHY